Concepedia

Veronica Novotny‐Diermayr

VN

18

Publications

1.3K

Citations

17

H-Index

2002

Active since

Affiliations

Institute of Molecular and Cell Biology(Current)

Experimental Drug Development Centre

Agency for Science, Technology and Research

National University of Singapore

National University Cancer Institute, Singapore

Veronica Novotny‐Diermayr is an author at Institute of Molecular and Cell Biology specializing in medicine, pharmacology, and tumor biology.

Top concepts

Publications per year

2002–2022

18

Publications

18

SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies

Stefan Hart, K C Goh, Veronica Novotny‐Diermayr et al. · Leukemia · 2011 · 195 citations · Full text

SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer

Veronica Novotny‐Diermayr, Kanda Sangthongpitag, Chang Hu et al. · Molecular Cancer Therapeutics · 2010 · 132 citations · Full text

, , +15

TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties

K C Goh, Veronica Novotny‐Diermayr, Stefan Hart et al. · Leukemia · 2011 · 128 citations

, , +9

Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia

Stefan Hart, K. C. Goh, Veronica Novotny‐Diermayr et al. · Blood Cancer Journal · 2011 · 106 citations · Full text

, , +17

A Novel Sequence in the Coiled-coil Domain of Stat3 Essential for Its Nuclear Translocation

Jing Ma, Tong Zhang, Veronica Novotny‐Diermayr et al. · Journal of Biological Chemistry · 2003 · 105 citations · Full text

Rows per page

1–5 of 18